UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2026
Commission File Number: 001-37385
Baozun Inc.
No. 1-9, Lane 510, West Jiangchang Road
Shanghai 200436
The People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form 20-F
x Form 40-F ¨
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
Baozun Inc. |
| |
|
|
| |
By: |
/s/ Vincent
Wenbin Qiu |
| |
Name: |
Vincent Wenbin Qiu |
| |
Title: |
Chief Executive Officer |
Date: March 30, 2026
Exhibit Index
| Exhibit 99.1 — Grant of Restricted Share
Unit Awards |
Safe Harbor Statement
This announcement contains forward-looking statements. These statements
are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking
statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,”
“future,” “intends,” “plans,” “believes,” “estimates,” “confident,”
“potential,” “continues,” “ongoing,” “targets,” “guidance,” “going forward,”
“outlook” or other similar expressions. Statements that are not historical facts, including but not limited to statements
about Baozun’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties.
A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but
not limited to Baozun’s filings with the United States Securities and Exchange Commission and its announcements, notices or other
documents published on the website of The Stock Exchange of Hong Kong Limited. All information provided in this announcement is as of
the date hereof and is based on assumptions that Baozun believes to be reasonable as of this date, and Baozun undertakes no obligation
to update such information, except as required under applicable law.
Exhibit 99.1
| 
| 1
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility
for the contents of this announcement, make no representation as to its accuracy or completeness and expressly
disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the
contents of this announcement.
Under our weighted voting rights structure, our share capital comprises Class A ordinary shares and Class B ordinary
shares. Each Class A ordinary share entitles the holder to exercise one vote, and each Class B ordinary share entitles
the holder to exercise ten votes, respectively, on any resolution tabled at our general meetings, except as may otherwise
be required by law or by the Rules Governing the Listing of Securities on the Stock Exchange of Hong Kong Limited
(the “ Listing Rules”) or provided for in our memorandum and articles of association. Shareholders and prospective
investors should be aware of the potential risks of investing in a company with a weighted voting rights structure. Our
American depositary shares, each representing three of our Class A ordinary shares, are listed on the Nasdaq Global
Select Market in the United States under the symbol BZUN.
Baozun Inc.
寶尊電商有限公司*
(A company controlled through weighted voting rights and incorporated in the Cayman Islands with limited liability)
(Stock Code: 9991)
GRANT OF RESTRICTED SHARE UNIT AWARDS
Grant of Restricted Share Unit Awards
Baozun Inc. (the “Company”, together with its consolidated subsidiaries and its affiliated
consolidated entities, the “Group”) hereby announces that on March 30, 2026 (Hong Kong time),
the Company granted and proposed to grant restricted share unit awards (the “RSUs”) under the
2022 share incentive plan of the Company (the “2022 Plan”) to certain grantees (the “Grantees”),
the details of which are set forth as follows:
Date of grant: March 30, 2026 (Hong Kong time) (the “Grant Date”)
Number of RSUs granted: 6,167,124 RSUs, details of the Grantees are as follows:
Name/Category
of Grantees Positions
Number of
RSUs
Percentage
of the total
issued shares of
the Company
(excluding
treasury shares)
on the Grant
Date
Mr. Vincent
Wenbin Qiu
(“Mr. Qiu”)
a director (the
“Director”) of
the Company
and the chief
executive
officer
1,678,320 0.96% |
| 
| 2
Name/Category
of Grantees Positions
Number of
RSUs
Percentage
of the total
issued shares of
the Company
(excluding
treasury shares)
on the Grant
Date
Mr. Junhua Wu
(“Mr. Wu”)
a Director and the
chief strategy
1,110,447 0.64%
officer
Ms. Catherine the chief financial 300,000 0.17%
Yanjie Zhu
(“Ms. Zhu”)
officer of the
Company
25 employees employees of the 3,078,357 1.77%
Total
Group
6,167,124 3.54%
Number of underlying
Class A ordinary shares of
the Company:
6,167,124 Class A ordinary shares (the “Shares”) or 2,055,708 American
depository shares (the “ADS(s)”) of the Company
Purchase price: The Grantees are not required to pay any purchase price for the Shares
issuable under the RSUs.
Closing price of
the Shares on the
date of grant:
HK$5.83 per Share, for Shares traded on the Stock Exchange on March
30, 2026 (Hong Kong time), being the trading day on the Stock Exchange
on the Grant Date.
US$2.095 per ADS, for ADSs traded on the Nasdaq Global Select Market
on March 27, 2026 (United States time), being the trading day on the
Nasdaq Global Select Market immediately before the Grant Date. |
| 
| 3
Performance target
and vesting period:
Subject to the satisfaction of the individual performance review and
satisfaction of certain milestones or performance targets relating to the
Group as set out in the award agreements applicable to the respective
Grantees, the vesting schedules are set as follows:
Name/CategoryNumber of Vesting Period Circumstances
of Grantees RSUs for any shorter
vesting period
Mr. Qiu 778,320 75% of the RSUs
shall be vested
on January 1,
2029; and 25%
of the RSUs
shall be vested
on January 1,
2030.
900,000 100% of the
RSUs shall
be vested on
September 30,
2026.
Not applicable
Grants of
RSUs with
performance
based vesting
conditions
according to
the terms and
conditions of
the 2022 Plan.
Mr. Wu 390,447 75% of the RSUs
shall be vested
on January 1,
2029; and 25%
of the RSUs
shall be vested
on January 1,
2030.
720,000 100% of the
RSUs shall
be vested on
September 30,
2026.
Not applicable
Grants of
RSUs with
performance
based vesting
conditions
according to
the terms and
conditions of
the 2022 Plan. |
| 
| 4
Name/Category Number of Vesting Period Circumstances
of Grantees RSUs for any shorter
vesting period
Ms. Zhu 300,000 75% of the RSUs
shall be vested
on January 1,
2029; and 25%
of the RSUs
shall be vested
on January 1,
2030.
Not applicable
25 employees 2,898,357 75% of the RSUs
shall be vested
on January 1,
2029; and 25%
Not applicable
of the RSUs shall
be vested on
January 1, 2030.
1 employee 180,000 100% of the RSUs
shall be vested
on September
30, 2026.
Grants of
RSUs with
performance
based vesting
conditions
according to
the terms and
conditions of the
2022 Plan.
Clawback mechanisms: Subject to the terms and conditions in the 2022 Plan, the RSUs may be
forfeited or clawback if the Grantees (i) seriously commit or persistently
breach or not comply with any policy of the Group or any applicable
laws and rules applicable to such Grantees, including but not limited to
the applicable employee handbook; (ii) engage in intentional misconduct
or gross negligence in such Grantees’ duties which result in a material
loss of the Group; (iii) engage in any gross misconduct; or (iv) engage in
any activity which is inimical, contrary or harmful to the interests of the
Company. |
| 
| 5
Arrangement for
the Group to provide
financial assistance to
a grantee to facilitate
the purchase of Shares:
None
The RSUs are subject to the terms and conditions of the 2022 Plan and award agreements
applicable to the Grantees. Details of the 2022 Plan are set out in Appendix IV – The 2022 Plan of
the circular of the Company dated October 5, 2022.
As of the date of this announcement, taking into account the proposed grants of RSUs to Mr.
Qiu and Mr. Wu, which are subject to the approval by shareholders (the “Shareholders”) of the
Company at the general meeting of the Company, 150,002 Shares remained available for future
grants under the 2022 Plan in accordance with the terms of the 2022 Plan, of which 15,002 Shares
are available for future grants to the service providers.
Proposed Grants of RSUs to Directors
As each of the proposed grants of RSUs to Mr. Qiu and Mr. Wu exceeds over 0.1% of the total
issued shares of the Company (excluding treasury shares) on the Grant Date, the proposed grants
of RSUs to Directors are subject to the approval of the Shareholders in general meeting where Mr.
Qiu/or Mr. Wu (as the case may be) and his associates (as defined in the Listing Rules) and all
core connected persons (as defined in the Listing Rules) of the Company shall abstain from voting
in favour for such proposed grants pursuant to the terms and conditions of the 2022 Plan and Rule
17.04 of the Listing Rules.
The Compensation Committee and the independent Directors have reviewed and considered the
proposed grants of RSUs to Mr. Qiu and Mr. Wu, and are of view that, (i) Mr. Qiu, as a Director
and the chief executive officer of the Company, and Mr. Wu, as a Director and the chief strategy
officer of the Company, have both made significant contributions to the Company in managing the
overall operations and improving the performance of the Company; (ii) the vesting arrangement for
the RSUs proposed to be granted to each of Mr. Qiu and Mr. Wu is performance-based and serves
as the Board’s appreciation and recognition of their contribution towards the growth of the Group;
and (iii) the RSUs proposed to be granted to Mr. Qiu and Mr. Wu will provide sufficient incentive
to retain Mr. Qiu and Mr. Wu and motivate them to create more value in the Group’s long-term
development. Therefore, the Compensation Committee and the independent Directors are of view
that the proposed grant of RSUs to Mr. Qiu and Mr. Wu and the vesting arrangement will closely
align the purpose of the 2022 Plan and the interests and benefits of the Group, the Board and
the management of the Group, and thus is appropriate and reasonable and in the interests of the
Company and its Shareholders as a whole.
Mr. Qiu and Mr. Wu are both beneficiaries of the weighted voting rights of the Company. Pursuant
to the note to Rule 17.04(1) of the Listing Rules, the nominating and corporate governance
committee of the Company have reviewed and fully considered the proposed grants of RSUs to
Mr. Qiu and Mr. Wu, including the reasons of such grants, and is of the view that, the grant of
RSUs to Mr. Qiu and Mr. Wu are fair and reasonable and in the interest of the Company and its
Shareholders as a whole. |
| 
| 6
General
An ordinary resolution will be proposed at the forthcoming annual general meeting of the Company
(the “AGM”) to be convened and held in 2026 for the Shareholders to consider and, if thought fit,
approve the proposed grants of RSUs to Mr. Qiu and Mr. Wu.
A circular containing, among other things, (i) further information on the proposed grants of RSUs
to Mr. Qiu and Mr. Wu; and (ii) a notice convening the AGM, are expected to be despatched to the
Shareholders in due course.
By order of the Board
Baozun Inc.
Mr. Vincent Wenbin Qiu
Chairman
Hong Kong, March 30, 2026
As at the date of this announcement, our board of directors comprises Mr. Vincent Wenbin Qiu as
the chairman, Mr. Junhua Wu, Dr. Jun Wang and Ms. Bin Yu as directors, and Mr. Yiu Pong Chan,
Mr. Steve Hsien-Chieng Hsia and Mr. Benjamin Changqing Ye as independent directors.
* For identification purpose only |